203 related articles for article (PubMed ID: 24118195)
1. Higher anti-tumour efficacy of platinum(IV) complex LA-12 is associated with its ability to bypass M-phase entry block induced in oxaliplatin-treated human colon cancer cells.
Vondálová Blanářová O; Jelínková I; Hyršlová Vaculová A; Sova P; Hofmanová J; Kozubík A
Cell Prolif; 2013 Dec; 46(6):665-76. PubMed ID: 24118195
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
Chiu SJ; Lee YJ; Hsu TS; Chen WS
Chem Biol Interact; 2009 Dec; 182(2-3):173-82. PubMed ID: 19735649
[TBL] [Abstract][Full Text] [Related]
3. LA-12 overcomes confluence-dependent resistance of HT-29 colon cancer cells to Pt (II) compounds.
Svihálková-Sindlerová L; Foltinová V; Vaculová A; Horváth V; Soucek K; Sova P; Hofmanová J; Kozubík A
Anticancer Res; 2010 Apr; 30(4):1183-8. PubMed ID: 20530425
[TBL] [Abstract][Full Text] [Related]
4. Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells.
Lauková J; Kozubík A; Hofmanová J; Nekvindová J; Sova P; Moyer MP; Ehrmann J; Hyršlová Vaculová A
PLoS One; 2015; 10(10):e0141020. PubMed ID: 26492315
[TBL] [Abstract][Full Text] [Related]
5. Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway.
Jelínková I; Šafaříková B; Vondálová Blanářová O; Skender B; Hofmanová J; Sova P; Moyer MP; Kozubík A; Kolář Z; Ehrmann J; Hyršlová Vaculová A
Biochem Pharmacol; 2014 Dec; 92(3):415-24. PubMed ID: 25285768
[TBL] [Abstract][Full Text] [Related]
6. Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells.
Herůdková J; Paruch K; Khirsariya P; Souček K; Krkoška M; Vondálová Blanářová O; Sova P; Kozubík A; Hyršlová Vaculová A
Neoplasia; 2017 Oct; 19(10):830-841. PubMed ID: 28888100
[TBL] [Abstract][Full Text] [Related]
7. Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells.
Hata T; Yamamoto H; Ngan CY; Koi M; Takagi A; Damdinsuren B; Yasui M; Fujie Y; Matsuzaki T; Hemmi H; Xu X; Kitani K; Seki Y; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Mol Cancer Ther; 2005 Oct; 4(10):1585-94. PubMed ID: 16227409
[TBL] [Abstract][Full Text] [Related]
8. Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatin.
Horváth V; Soucek K; Svihálková-Sindlerová L; Vondrácek J; Blanárová O; Hofmanová J; Sova P; Kozubík A
Invest New Drugs; 2007 Oct; 25(5):435-43. PubMed ID: 17520175
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
[TBL] [Abstract][Full Text] [Related]
10. The effect of cellular environment and p53 status on the mode of action of the platinum derivative LA-12.
Roubalová E; Kvardová V; Hrstka R; Borilová S; Michalová E; Dubská L; Müller P; Sova P; Vojtesek B
Invest New Drugs; 2010 Aug; 28(4):445-53. PubMed ID: 19499188
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
12. Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells.
Kalimutho M; Minutolo A; Grelli S; Federici G; Bernardini S
Acta Pharmacol Sin; 2011 Nov; 32(11):1387-96. PubMed ID: 21927014
[TBL] [Abstract][Full Text] [Related]
13. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
[TBL] [Abstract][Full Text] [Related]
14. The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin.
Hrstka R; Powell DJ; Kvardova V; Roubalova E; Bourougaa K; Candeias MM; Sova P; Zak F; Fåhraeus R; Vojtĕsek B
Anticancer Drugs; 2008 Apr; 19(4):369-79. PubMed ID: 18454047
[TBL] [Abstract][Full Text] [Related]
15. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
[TBL] [Abstract][Full Text] [Related]
16. Aloperine induces G2/M phase cell cycle arrest and apoptosis in HCT116 human colon cancer cells.
Zhang L; Zheng Y; Deng H; Liang L; Peng J
Int J Mol Med; 2014 Jun; 33(6):1613-20. PubMed ID: 24682388
[TBL] [Abstract][Full Text] [Related]
17. Repression of cell cycle-related proteins by oxaliplatin but not cisplatin in human colon cancer cells.
Voland C; Bord A; Péleraux A; Pénarier G; Carrière D; Galiègue S; Cvitkovic E; Jbilo O; Casellas P
Mol Cancer Ther; 2006 Sep; 5(9):2149-57. PubMed ID: 16985047
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human colon adenocarcinoma cells.
Dasiram JD; Ganesan R; Kannan J; Kotteeswaran V; Sivalingam N
Biomed Pharmacother; 2017 Feb; 86():373-380. PubMed ID: 28011386
[TBL] [Abstract][Full Text] [Related]
19. The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin.
Kvardova V; Hrstka R; Walerych D; Muller P; Matoulkova E; Hruskova V; Stelclova D; Sova P; Vojtesek B
Mol Cancer; 2010 Jun; 9():147. PubMed ID: 20550649
[TBL] [Abstract][Full Text] [Related]
20. Aqueous extract of Curcuma aromatica induces apoptosis and G2/M arrest in human colon carcinoma LS-174-T cells independent of p53.
Hu B; Shen KP; An HM; Wu Y; Du Q
Cancer Biother Radiopharm; 2011 Feb; 26(1):97-104. PubMed ID: 21348775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
